基本信息
views: 5
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Joel Kleinman, M.D., Ph.D. is the Associate Director, Clinical Sciences and the Co-Director of the Molecular Neuropathology Section at the Lieber Institute for Brain Development (LIBD), Johns Hopkins University in Baltimore, MD. He is a Professor in the Department of Psychiatry & Behavioral Sciences at the Johns Hopkins University School of Medicine. Dr. Kleinman is also on the board of directors for the Sheppard-Pratt Lieber Research Institute, a clinical research center focused on understanding the biology of schizophrenia, autism, and other developmental neuropsychiatric disorders.
Dr. Kleinman received his B.S. in Biochemistry in 1966, his M.D. in 1973, and his Ph.D. in Pharmacology in 1974 from the University of Chicago. He interned at San Francisco General Hospital (University of California Medical School in San Francisco) and completed a residency in psychiatry at Massachusetts Mental Health Center (Harvard Medical School) as well as a residency in Neurology at the George Washington University School of Medicine.
Over the last 41 years at the NIMH and LIBD he has helped to amass what is widely regarded as one of the best collections of postmortem human brains for the study of the molecular biology of brain development and related disorders, especially schizophrenia. He has been both a pioneer and leader in this area of research with over 350 peer-reviewed papers. Recently, his research has focused on allelic variation, alternative transcripts and epigenetic modifications in human fetal and postnatal brain development, schizophrenia and a number of other psychiatric disorders including bipolar disorder, depression and PTSD.
Dr. Kleinman received his B.S. in Biochemistry in 1966, his M.D. in 1973, and his Ph.D. in Pharmacology in 1974 from the University of Chicago. He interned at San Francisco General Hospital (University of California Medical School in San Francisco) and completed a residency in psychiatry at Massachusetts Mental Health Center (Harvard Medical School) as well as a residency in Neurology at the George Washington University School of Medicine.
Over the last 41 years at the NIMH and LIBD he has helped to amass what is widely regarded as one of the best collections of postmortem human brains for the study of the molecular biology of brain development and related disorders, especially schizophrenia. He has been both a pioneer and leader in this area of research with over 350 peer-reviewed papers. Recently, his research has focused on allelic variation, alternative transcripts and epigenetic modifications in human fetal and postnatal brain development, schizophrenia and a number of other psychiatric disorders including bipolar disorder, depression and PTSD.
Research Interests
Papers共 404 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Leonardo Sportelli,Daniel P. Eisenberg,Roberta Passiatore,Enrico D'Ambrosio,Linda A. Antonucci, Jasmine S. Bettina, Qiang Chen,Aaron L. Goldman,Michael D. Gregory,Kira Griffiths,Thomas M. Hyde,Joel E. Kleinman,
NATURE COMMUNICATIONSno. 1 (2024): 3342-3342
Nikolaos P Daskalakis,Artemis Iatrou,Chris Chatzinakos,Aarti Jajoo,Clara Snijders,Dennis Wylie, Christopher P DiPietro, Ioulia Tsatsani,Chia-Yen Chen,Cameron D Pernia,Marina Soliva-Estruch,Dhivya Arasappan,
Science (New York, N.Y.)no. 6698 (2024): eadh3707-eadh3707
medRxiv : the preprint server for health sciences (2024)
medrxiv(2024)
bioRxiv : the preprint server for biology (2024)
Nature communicationsno. 1 (2024): 3980-3980
Ethan Tietze,Andre Rocha Barbosa,Bruno Araujo,Veronica Euclydes, Bailey Spiegelberg,Hyeon Jin Cho, Yong Kyu Lee, Yanhong Wang, Alejandra Mccord, Alan Lorenzetti,Arthur Feltrin,Joyce van de Leemput,
SCIENTIFIC REPORTSno. 1 (2024)
Nature neuroscienceno. 6 (2024): 1064-1074
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn